MANILA (Reuters) – Russia’s Gamaleya Research Institute has applied to the Philippine health regulator for emergency use authorization of its COVID-19 vaccine, the regulator said late Friday.
Gamaleya’s emergency use application is the third the Philippine Food and Drug Administration has received after Pfizer and AstraZeneca both made similar applications.
(Reporting by Neil Jerome Morales; Editing by Leslie Adler)
